Despite the advancement of cell treatments like PRP or Platelet rich plasma, scientific journals & their authors oftentimes fail to adequately describe the type of formulation used in a particular study. For example there is great variability from one clinic to the next, in terms of how the PRP is prepared. For example, including white and red blood cells or not and the platelet concentration or dose are important aspects to be shared when understanding results of a study.
After a meeting by the American Academy of Orthopedic Surgeons in 2018, a standard for minimal reporting guidelines was established. Dr Sampson has also published on a new classification (PLRA) to help detail the type of PRP used when reporting results for best interpretation. Moving forward it’s important the doctors and their patients understand there are different formulations of PRP and that these should be clarified in all scientific journals to better understand and advance the science. To read more, click here.
